Demyelinating Disorder Clinical Trials

6 recruitingLast updated: June 18, 2026

There are 6 actively recruiting demyelinating disorder clinical trials across 2 countries. Studies span Not Applicable, Phase 1. Top locations include Beijing, Beijing Municipality, China, Beijing, China, Guangzhou, Guangdong, China. Updated daily from ClinicalTrials.gov.


Demyelinating Disorder Trials at a Glance

6 actively recruiting trials for demyelinating disorder are listed on ClinicalTrialsFinder across 4 cities in 2 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Beijing, Beijing, and Guangzhou. Lead sponsors running demyelinating disorder studies include Xuanwu Hospital, Beijing, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, and Yale University.

Browse demyelinating disorder trials by phase

Treatments under study

About Demyelinating Disorder Clinical Trials

Looking for clinical trials for Demyelinating Disorder? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Demyelinating Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Demyelinating Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Not Applicable

Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases

Acute Disseminated EncephalomyelitisMS (Multiple Sclerosis)Transcranial Alternating Current Stimulation+2 more
Xuanwu Hospital, Beijing128 enrolled1 locationNCT07087873
Recruiting
Not Applicable

Transcranial Electrical Stimulation for Treating Chronic Pain in Inflammatory Demyelinating Diseases

Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System
Xuanwu Hospital, Beijing80 enrolled1 locationNCT06942611
Recruiting
Not Applicable

Effects of Transcranial Electrical Stimulation on Cognitive Impairment in CNS Inflammatory Demyelinating Diseases

Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System
Xuanwu Hospital, Beijing85 enrolled1 locationNCT07029386
Recruiting
Phase 1

Exploring the Utility of [18F]3F4AP for Demyelination Imaging

Alzheimer's Disease(AD)MCIDemyelinating Disorders+3 more
Yale University105 enrolled1 locationNCT06999434
Recruiting
Not Applicable

Effectiveness of Personalized Alternating Current Stimulation for Treating Emotional Disorders in CNS Demyelination Patients

Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System
Xuanwu Hospital, Beijing65 enrolled1 locationNCT06933537
Recruiting

Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases

Clinically Isolated SyndromeAcute Disseminated EncephalomyelitisMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+3 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University450 enrolled1 locationNCT06541626